Kezar Life Sciences, Inc.

KZR

Kezar Life Sciences, Inc.

KZR

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2025-07-02Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,275,448Shares Outstanding:7,343,909Institutional Ownership Pct.:58.22%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	66	72	39	34	37	42	35	28	33	35	26	28
Marketable Securities Current	-	0	51	66	77	90	114	136	147	166	192	208
Accounts Receivable Net Current	-	-	-	-	-	-	-	-	-	-	7	-
Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	4	6
Other Assets Current	-	-	-	-	-	-	-	-	-	-	1	1
Prepaid Expense And Other Assets Current	1	3	4	4	6	5	8	3	6	6	-	-
Assets Held For Sale Not Part Of Disposal Group Cu…	0	1	-	-	-	0	-	-	-	-	-	-
Assets Current	68	76	95	105	120	137	156	168	186	207	231	244
Property Plant And Equipment Net	0	0	2	2	3	3	3	3	4	4	4	5
Operating Lease Right Of Use Asset	0	1	1	1	2	2	2	2	4	5	8	9
Other Assets Noncurrent	-	0	0	1	1	2	2	7	6	6	6	7
Assets	68	77	98	109	125	145	164	180	199	221	249	263
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	0	1	1	1	2	4	3	2	5	8	3	2
Accrued Liabilities Current	-	4	-	-	-	8	-	-	-	6	-	-
Operating Lease Liability Current	1	2	3	4	4	4	3	3	3	3	3	3
Long Term Debt Current	-	-	-	-	-	-	4	3	1	-	-	-
Debt Current	-	0	5	5	5	5	-	-	-	0	-	-
Liabilities Current	3	7	13	14	17	20	20	17	16	18	17	14
Liabilities	3	7	15	17	22	28	30	29	30	34	33	31
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	0	0	0	0	1	2	3	4	5	6	7	7
Long Term Debt Noncurrent	-	0	1	3	4	5	6	8	9	10	10	10
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	562	561	559	557	554	552	548	545	542	538	535	528
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	-0	-0	-0	0	-0	-0	-0	-1	-1
Retained Earnings Accumulated Deficit	-496	-491	-476	-465	-451	-434	-414	-394	-372	-351	-319	-295
Stockholders Equity	65	70	83	92	103	117	134	151	169	188	216	232
Liabilities And Stockholders Equity	68	77	98	109	125	145	164	180	199	221	249	263
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	7	7	7	7	7	7	7	7	7	7	7	7
Shares Outstanding	7	7	7	7	7	7	7	7	7	7	7	7
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-	-	-	-	-	-	-	-	-	-	-	-
2025	4.76%	9.05%	-3.57%	3.83%	0.00%	58.42%	1.46%	2.11%	-1.46%	18.23%	-	-
2024	-15.06%	-26.56%	-18.24%	-3.57%	37.45%	24.27%	-9.21%	-8.41%	-13.48%	-26.24%	-27.84%	-18.62%
2023	-	-	-	-23.41%	-41.95%	-64.39%	18.30%	26.52%	29.96%	-6.18%	0.87%	-18.35%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	24.46	11.52	7.06	7.29	7.09	6.76	7.65	9.58	11.49	11.66	13.83	17.73
Quick Ratio	23.98	11.01	6.74	7.02	6.74	6.51	7.26	9.38	11.13	11.35	13.56	17.29
Working Capital	64.80M	69.16M	81.13M	90.34M	103.36M	117.16M	135.95M	150.12M	169.45M	189.21M	213.84M	229.77M
Leverage & Debt
Debt to Equity	0.04	0.09	0.18	0.19	0.22	0.24	0.22	0.19	0.18	0.18	0.15	0.13
Interest Coverage TTM	-161.73	-91.07	-100.93	-72.00	-73.43	-75.25	-64.65	-67.17	-70.01	-71.89	-64.58	-63.84
Debt Ratio	0.04	0.09	0.15	0.16	0.18	0.19	0.18	0.16	0.15	0.15	0.13	0.12
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.03	0.03	0.03	0.00
Days Sales Outstanding TTM	-	-	-	-	-	-	-	-	-	-	365.00	-
Receivables Turnover TTM	-	-	-	-	-	-	-	-	-	-	1.00	-
Per Share Metrics
Diluted EPS TTM	-6.16	-7.66	-8.43	-9.68	-10.76	-11.49	-13.13	-13.53	-13.92	-14.04	-12.08	-11.39
Free Cash Flow Per Share TTM	-5.72	-7.08	-7.74	-8.80	-9.39	-10.18	-10.47	-10.87	-11.70	-11.50	-11.10	-10.67
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-1,531.57%	-1,580.16%	-1,591.77%	-1,383.84%	-
Net Profit Margin TTM	-	-	-	-	-	-	-	-1,408.11%	-1,447.56%	-1,455.29%	-1,254.16%	-
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-	-	-	-	-
Net Income Growth (1Y)	-42.48%	-33.08%	-35.57%	-28.18%	-22.40%	-17.80%	9.10%	19.43%	36.17%	49.28%	36.60%	35.56%
EPS Growth (1Y)	-42.78%	-33.33%	-35.81%	-28.44%	-22.67%	-18.19%	8.68%	18.80%	35.29%	38.62%	35.61%	20.25%
Calculated Values
Free Cash Flow TTM	-42.03M	-51.79M	-56.66M	-64.34M	-68.58M	-74.24M	-76.39M	-79.22M	-85.16M	-83.46M	-80.70M	-77.32M
Net Debt	-66.23M	-71.88M	-32.28M	-26.45M	-27.91M	-31.42M	-24.60M	-18.08M	-22.90M	-25.42M	-16.49M	-18.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-07-02Sale

Owner: Schiller, Mark C.

Title: Chief Operating Officer

Shares: 561

Price/Share: $4.28

Value: $2,401.08

Shares Owned: 2,739

Relationship: Officer

Ownership: Direct

2025-07-02Sale

Owner: Chiang, Pichi Luo

Title: SVP, Corporate Controller

Shares: 264

Price/Share: $4.28

Value: $1,129.92

Shares Owned: 2,711

Relationship: Officer

Ownership: Direct

2024-07-02Sale

Owner: Schiller, Mark C.

Title: Chief Legal Officer

Shares: 6,688

Price/Share: $0.58

Value: $3,879.04

Shares Owned: 33,007

Relationship: Officer

Ownership: Direct

2023-02-06Sale

Owner: Morningside, Venture Inve…

Title: -

Shares: 40,000

Price/Share: $6.88

Value: $275,200.00

Shares Owned: 5,447,993

Relationship: TenPercentOwner

Ownership: Direct

2023-02-01Sale

Owner: Morningside, Venture Inve…

Title: -

Shares: 40,000

Price/Share: $6.95

Value: $278,000.00

Shares Owned: 5,562,993

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-07-02	Schiller, Mark C.	Officer	Chief Operating Officer	Direct	Sale	561	4.28	$2,401.08	2,739	4
2025-07-02	Chiang, Pichi Luo	Officer	SVP, Corporate Controller	Direct	Sale	264	4.28	$1,129.92	2,711	4
2024-07-02	Schiller, Mark C.	Officer	Chief Legal Officer	Direct	Sale	6,688	0.58	$3,879.04	33,007	4
2023-02-06	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	40,000	6.88	$275,200.00	5,447,993	4
2023-02-01	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	40,000	6.95	$278,000.00	5,562,993	4
2023-01-31	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	30,000	7.08	$212,400.00	5,602,993	4
2023-01-25	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	50,000	6.85	$342,500.00	5,662,993	4
2023-01-24	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	80,000	6.98	$558,400.00	5,712,993	4
2023-01-17	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	6,114	6.79	$41,514.06	5,872,993	4
2023-01-13	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	1,971	7.15	$14,092.65	5,879,107	4
2023-01-06	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	3,000	6.89	$20,670.00	5,886,078	4
2023-01-04	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	30,000	7.17	$215,100.00	5,901,240	4
2022-10-04	Morningside, Venture Inve…	TenPercentOwner	-	Direct	Sale	3,612	8.82	$31,857.84	6,076,740	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

58.22%

Inst. Shares: 4,275,448

Shares Outstanding: 7,343,909

2025-12-31

58.57%

Inst. Shares: 4,285,259

Shares Outstanding: 7,316,890

2025-09-30

55.61%

Inst. Shares: 4,072,622

Shares Outstanding: 7,323,106

2025-06-30

59.39%

Inst. Shares: 4,341,686

Shares Outstanding: 7,311,032

2025-03-31

57.42%

Inst. Shares: 4,194,847

Shares Outstanding: 7,305,658

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,275,448	7,343,909	58.22%
2025-12-31	4,285,259	7,316,890	58.57%
2025-09-30	4,072,622	7,323,106	55.61%
2025-06-30	4,341,686	7,311,032	59.39%
2025-03-31	4,194,847	7,305,658	57.42%
2024-12-31	4,055,039	7,290,245	55.62%
2024-09-30	3,606,854	7,296,222	49.43%
2024-06-30	3,731,087	7,284,587	51.22%
2024-03-31	4,117,795	7,279,991	56.56%
2023-12-31	4,624,995	7,255,365	63.75%
2023-09-30	5,384,116	7,268,165	74.08%
2023-06-30	5,572,229	7,246,185	76.90%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Kezar Life Sciences, Inc. (KZR) — SEC Financial Statements & Analysis

Kezar Life Sciences, Inc. (KZR) is a pharmaceutical preparations company, incorporated in DE. Kezar Life Sciences, Inc. trades on Nasdaq as: KZR. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Kezar Life Sciences, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.04x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.04x

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Kezar Life Sciences, Inc. in?

Kezar Life Sciences, Inc. (KZR) operates in the Pharmaceutical Preparations industry.

What exchange does KZR trade on?

Kezar Life Sciences, Inc. (KZR) trades on the Nasdaq.

Where is Kezar Life Sciences, Inc. incorporated?

Kezar Life Sciences, Inc. is incorporated in DE.